Dyne Therapeutics, Inc. · NASDAQ:DYN
Ra Capital Management, L.P. reported a 8.50% stake in Dyne Therapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 15, 2025
Ra Capital Management, L.P. reported a 8.50% stake in Dyne Therapeutics, Inc., 9,714,392 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G/A).
- Stake
- 8.50%
- Shares
- 9,714,392
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| RA Capital Management, L.P. | 8.50% | 9,714,392 |
| Peter Kolchinsky | 8.50% | 9,714,392 |
| Rajeev Shah | 8.50% | 9,714,392 |
| RA Capital Healthcare Fund, L.P. | 8.50% | 9,714,392 |
Source
Related
- Dyne Therapeutics, Inc.
- Ra Capital Management, L.P.
- Dyne Therapeutics, Inc. shareholders
- Schedule 13G/A · Ra Capital Management, L.P. · Nov 14, 2025
- Form 4 · Kerr Douglas · Oct 22, 2026
- Form 4 · Posner Brian S · Oct 6, 2026
- Form 4 · Cox John · Sep 8, 2026
- Form 4 · Kerr Douglas · Sep 8, 2026
- Form 4 · Friedl-Naderer Johanna · Sep 8, 2026